Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria

被引：104

作者：

Wareham, NJ ^{[1
]}

Griffin, SJ ^{[1
]}

机构：

[1] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2001年 / 322卷 / 7292期

关键词：

D O I：

10.1136/bmj.322.7292.986

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：986 / 988

页数：3

共 29 条

[1]

Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO

[2]

2-S

[3]

*AUD COMM, 2000, TEST TIM REV DIAB SE

[4]

Borch-Johnsen K, 1999, LANCET, V354, P617

[5] The relationship between glucose and incident cardiovascular events [J].

Coutinho, M ;

Gerstein, HC ;

Wang, Y ;

Yusuf, S .

DIABETES CARE, 1999, 22 (02) :233-240

[6]

Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757

[7] SCREENING FOR NIDDM IN NONPREGNANT ADULTS - A REVIEW OF PRINCIPLES, SCREENING-TESTS, AND RECOMMENDATIONS [J].

ENGELGAU, MM ;

AUBERT, RE ;

THOMPSON, TJ ;

HERMAN, WH .

DIABETES CARE, 1995, 18 (12) :1606-1618

[8] Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria:: the Steno type 2 randomised study [J].

Gæde, P ;

Vedel, P ;

Parving, HH ;

Pedersen, O .

LANCET, 1999, 353 (9153) :617-622

[9]

Gerstein HC, 2000, LANCET, V355, P253

[10] Dysglycaemia and risk of cardiovascular disease [J].

Gerstein, HC ;

Yusuf, S .

LANCET, 1996, 347 (9006) :949-950

← 1 2 3 →